3D Systems Partners with Enhatch to Scale Personalized Medical Device Delivery

Rhea-AI Summary

3D Systems (NYSE:DDD) has partnered with Enhatch to enhance the design and delivery of patient-specific medical devices. This collaboration aims to automate surgical workflows using artificial intelligence, improving efficiency and cost-effectiveness. The Intelligent Surgery Ecosystem developed by Enhatch will streamline patient-specific processes, integrating with 3D Systems' existing capabilities in surgical planning. The partnership supports the growing demand for personalized medical solutions, potentially leading to better patient outcomes and reduced procedure times.

Positive

• Partnership with Enhatch aims to enhance efficiency in patient-specific medical device design and delivery.
• Utilization of AI technology will streamline surgical workflows, potentially improving patient outcomes.
• 3D Systems has a strong background, having planned over 140,000 patient-specific cases and manufactured more than two million implants.

Negative

• None.

• Enhatch is building an open ecosystem of technologies powered by artificial intelligence to personalize and accelerate the entire surgical workflow
  
• Partnership intended to merge advanced capabilities of each organization to make design and delivery of patient-specific medical devices more efficient

ROCK HILL, S.C. and HOBOKEN, N.J. and TULSA, Okla., March 23, 2022 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD), the leading additive manufacturing solutions partner, and Enhatch Inc, the Hoboken, New Jersey and Tulsa, Oklahoma-based developer of the Intelligent Surgery Ecosystem, announced they have entered a partnership. The technologies which drive Intelligent Surgery streamline and scale the design and delivery of patient-specific medical devices by automating the process. Incorporating these capabilities into 3D Systems’ proven workflow for patient-specific solutions—which includes advanced software, expert treatment planning services, custom implants and instrumentation design, and industry-leading production processes—will help more efficiently meet the growing demand for personalized medical devices.

3D Systems partners with medical device manufacturers to offer its VSP^® surgical planning solutions to support craniomaxillofacial and orthopedic medical specialties to help reduce procedure time and improve surgical outcomes. Likewise, Enhatch develops software applications powered by artificial intelligence to streamline every element of the patient-specific digital workflow. Enhatch is the first company to market an ecosystem of surgical technologies driven by artificial intelligence, which helps evaluate and mitigate potential risks in the surgical planning process. Combining the application and technology expertise of both companies creates an optimized, automated, and scalable medical device workflow.

“Our partnership with Enhatch will enable us to deliver the healthcare industry’s most comprehensive approach to additive manufacturing,” said Menno Ellis, executive vice president, healthcare solutions, 3D Systems. “Integrating these technologies and capabilities into 3D Systems’ surgical planning solutions will make processes more efficient, trackable, and cost-effective. This is another step in our ongoing commitment to innovation that helps our customers remain at the forefront of medical device development and healthcare delivery.”

Peter Verrillo, co-founder and CEO of Enhatch, agrees, “Enhatch is proud to welcome 3D Systems to the Intelligent Surgery Ecosystem. Healthcare ecosystems have tremendous potential to disrupt and reshape the entire industry, leading to improved patient outcomes, faster, more accurate, and safer procedures. Enhatch and 3D Systems have a shared goal of bringing surgeons and industry together with the best leading-edge technologies available.”

As a pioneer in personalized healthcare solutions, 3D Systems has worked with surgeons over the last decade to plan more than 140,000 patient-specific cases, and manufacture more than two million implants and instruments for 100+ CE-marked and FDA-cleared devices from its world-class, FDA registered, ISO 13485-certified facilities in Littleton, Colorado, and Leuven, Belgium. The company will feature its solutions, including its partnership with Enhatch, in its booth (#1014) at the AAOS 2022 Annual Meeting, March 23-25 at McCormick Place in Chicago, Illinois. For more information, please visit the company’s website.

Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements, including the ability of Enhatch and 3D Systems to consummate the transaction as expected. In many cases, forward-looking statements can be identified by terms such as "believes," "belief," "expects," "may," "will," "estimates," "intends," "anticipates" or "plans" or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions, and current expectations and may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings "Forward-Looking Statements" and "Risk Factors" in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at which such performance or results will be achieved. The forward-looking statements included are made only as of the date of the statement. 3D Systems and Enhatch undertake no obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, subsequent events or circumstances or otherwise, except as required by law.

About 3D Systems
More than 30 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at www.3dsystems.com.

About Enhatch
Enhatch is a medical technology company that created the industry’s first Intelligent Surgery Ecosystem, connecting companies, technologies, and surgeons to provide insights from every surgery, patient, and device to elevate patient care. The Intelligent Surgery Ecosystem harnesses the power of AI to streamline each phase of orthopedic surgery, achieving better patient outcomes, unprecedented efficiency and accuracy in patient-specific procedures, and a new level of precision to surgical devices and techniques. To learn more, please visit www.enhatch.com.  

3D Systems Corporation
333 Three D Systems Circle
Rock Hill, SC 29730
www.3dsystems.com 
NYSE:DDD

Investor Contact:   investor.relations@3dsystems.com
Media Contact:      press@3dsystems.com

Enhatch Inc                                
2 Hudson Place – Fourth Floor
Hoboken, NJ 07030
www.enhatch.com

Media Contact : press@enhatch.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8d43da68-1665-4c7c-8ea1-17fa34ace798

                                                                                                                
                                                                       
                                                                       
                                               
                                                                       
                                                                       

FAQ

What is the partnership between 3D Systems and Enhatch about?

The partnership focuses on merging technologies to improve the design and delivery of patient-specific medical devices through automation and AI.

How will this partnership benefit 3D Systems (DDD) shareholders?

The partnership is expected to enhance operational efficiency and potentially lead to increased demand for personalized medical devices, benefiting shareholders.

When was the partnership between 3D Systems and Enhatch announced?

The partnership was announced on March 23, 2022.

What technologies are involved in the 3D Systems and Enhatch partnership?

The partnership involves AI technologies to optimize surgical workflows and improve the delivery of patient-specific medical devices.